Table 1 Correlation between BDH2 expression in GC tissues and clinicopathological features of GC patients
Clinicopathological parameter | N | BDH2 expression | p value | |
|---|---|---|---|---|
Low 127 | High 44 | |||
Gender | Â | Â | Â | 0.371 |
 Male | 111 | 80(72.1%) | 31(27.9%) |  |
 Female | 60 | 47(78.3%) | 13(21.7%) |  |
Age (years) | Â | . | . | 0.433 |
 ≤60 | 73 | 52(71.2%) | 21(28.8%) |  |
 > 60 | 98 | 75(76.5%) | 23(23.5%) |  |
Degree of differentiation | Â | Â | Â | 0.177 |
 Well | 18 | 11(61.1%) | 7(38.9%) |  |
 Moderate/Poor | 153 | 116(75.8%) | 37(24.2%) |  |
Tumor diameter (cm) | Â | Â | Â | 0.124 |
 < 5 | 112 | 79(70.5%) | 33(29.5%) |  |
 ≥5 | 59 | 48(81.4%) | 11(18.6%) |  |
Tumor localization | Â | Â | Â | 0.536 |
 Up | 19 | 13(68.4%) | 6(31.6%) |  |
 Middle/Down | 152 | 114(75.0%) | 38(25.0%) |  |
TNM stage | Â | Â | Â | 0.021 |
 I + II | 95 | 64(67.3%) | 31(32.7%) |  |
 III | 76 | 63(82.9%) | 13(17.1%) |  |
Depth of invasion | Â | Â | Â | 0.008 |
 T1 + T2 | 72 | 46(63.8%) | 26(36.2%) |  |
 T3 + T4 | 99 | 81(81.8%) | 18(18.2%) |  |
Lymph node metastasis | Â | Â | Â | 0.047 |
 Negative | 79 | 53(67.1%) | 26(32.9%) |  |
 Positive | 92 | 74(80.4%) | 18(19.6%) |  |